Progyny Executive Compensation
Progyny is a publicly traded company in the Healthcare sector.
Named Executive Officers — FY2025
Compensation Analysis
Computed directly from SEC-sourced figures tracked on this page — not a general description.
Progyny discloses FY2025 compensation for 6 named executive officers, totaling $7.1M. Peter Anevski, the Chief Executive Officer, accounts for 42% of that combined total.
Peter Anevski's total compensation rose 423% year-over-year, from $568,000 in FY2024 to $3.0M in FY2025.
Cash compensation (salary plus bonus) made up 44% of Progyny's FY2025 tracked executive pay, with stock awards accounting for 125%. That's notably more stock-weighted than the typical Healthcare company in this dataset, where stock awards average 0% of tracked pay.
Among 78 other Healthcare companies in this dataset, Progyny's combined tracked executive pay of $7.1M ranks in the 36th percentile (industry median: $13.6M). Its highest-paid executive, Peter Anevski, ranks in the 24th percentile for top-executive pay in the sector (industry median: $6.3M).